Posts Tagged ‘harm reduction’

FDA Approves Narcan For Over-The-Counter Purchase

Wednesday, March 29th, 2023

Per NPR:

The overdose-reversing drug Narcan could soon be available to buy over the counter without a prescription, the Food and Drug Administration announced Wednesday.

The FDA’s approval of the nasal spray Narcan — the brand name for the drug naloxone — means the medication could be more widely available across the U.S. as the country continues to grapple with an opioid epidemic.

“Today’s action paves the way for the life-saving medication to reverse an opioid overdose to be sold directly to consumers in places like drug stores, convenience stores, grocery stores and gas stations, as well as online,” the FDA said in a statement.

Emergent BioSolutions, the drug company that produces Narcan, said on Wednesday that it hoped to make the nasal spray available on store shelves and at online retailers by late summer. It did not immediately say how much it would cost.

HVCS offers free Narcan trainings and kits. Talk to our Health Hub program for more information on free trainings near you.

“Today’s landmark FDA OTC approval for Narcan Nasal Spray marks a historic milestone as we have delivered on our commitment to make this important emergency treatment widely accessible, given the alarming rates of opioid overdoses occurring across the country,” Emergent BioSolutions CEO Robert G. Kramer said in a statement.

Some states and harm-reduction groups have offered naloxone for free to residents. But typically those who wanted to buy Narcan had to obtain it at a pharmacy with a prescription.

Public health experts, harm-reduction advocates and many politicians have argued that those barriers meant fewer people would get the life-saving medication they needed in time.

The FDA approval comes as the U.S. continues to see a staggering number of opioid-related deaths, driven in large part by the spread of synthetic opioids such as illicit fentanyl.

According to data from the Centers for Disease Control and Prevention, there were 101,751 reported fatal overdoses in the 12-month period ending in October.

“We can prevent overdoses and save lives by making naloxone more accessible, and at the same time, we can ensure equitable access to essential health care,” Health and Human Services Secretary Xavier Becerra said in a statement.

The specific dose approved for over-the-counter sales is the 4 milligram (mg) naloxone hydrochloride nasal spray. Other formulations and dosages of the drug would still require a prescription, the FDA said.

The administration first approved Narcan nasal spray in 2015 as a prescription drug.

New York State Department of Health Launches New Harm Reduction Campaign to Help Reduce Overdoses

Friday, February 10th, 2023

“Safer Choices” Campaign Designed to Promote Tools and Knowledge to Reduce Overdose Deaths in New York

ALBANY, N.Y. (February 9, 2023) – The New York State Department of Health today announced the launch of a new harm reduction campaign, “Safer Choices,” to help prevent overdose deaths across New York. The multi-media campaign, starting with a focus on social media platforms and web-based resources, is meant to equip individuals with an understanding of how to reduce overdose, as deadly fentanyl continues to be found in a wide variety of drugs. The campaign also continues to emphasize the importance of naloxone as a life-saving tool in the event of an overdose.   

“To help reduce the number of overdose deaths across the state, we need to make sure people who use drugs, and their family members and friends, know how to reduce the risk of overdose and how to respond should an overdose occur,” Acting State Health Commissioner Dr. James McDonald said. “This new campaign will not only save lives, but it will also serve to help reduce the bias and discrimination associated with a substance use disorder diagnosis.”

The campaign shares helpful information and steps for family members, friends, and persons who use drugs. Tips for family members and friends strongly recommending carrying naloxone in case they witness an overdose, as well as information about Opioid Overdose Training programs across the state and about the Naloxone Co-payment Assistance Program (N-CAP), which can  cover co-payments for naloxone of up to $40.

These important messages focus on other life-saving steps that can be taken, which include testing drugs for fentanyl contamination. Fentanyl, a synthetic opioid that is 50-100 times stronger than heroin, has been found in powder cocaine, crack cocaine, methamphetamine, molly/MDMA, counterfeit Xanax, other pills, and powder sold as heroin. In addition, the campaign advises individuals to never use opioids and other drugs alone, and to know that, in case of an overdose, calling 911 will not result in a possession charge. Persons who use drugs are also encouraged to carry naloxone and know how to administer this life-saving drug.

More information about the new harm reduction campaign can be found at https://www.health.ny.gov/saferchoices.

This latest campaign builds on the Department’s ongoing work to support a variety of harm reduction initiatives. Other programs include the Local Health Department Initiative, providing funding to 24 county health departments with the highest overdose rates outside of New York City to bolster primary care, corrections, harm reduction, emergency departments, public safety, and more; over 900 registered Opioid Overdose Prevention Programs, which provide training to non-medical individuals to recognize opioid overdoses and provide naloxone at no cost to the participant. The Department also operates New York MATTERS, an electronic referral system for connecting individuals with opioid use disorder to local treatment and harm reduction services.

Additionally, the State has authorized 25 Syringe Exchange Programs (SEPs) with over 81 sites statewide. SEPs remain at the forefront of innovation in addressing the needs of New Yorkers who use drugs and lead in the distribution of naloxone to New Yorkers vulnerable to overdose. The State’s 14 Drug User Health Hubs have been built upon the long-standing foundation of SEPs. These Hubs focus on reducing overdose by providing access to buprenorphine, building safety plans with people who have experienced a non-fatal overdose and equipping participants with naloxone.

Governor Hochul’s administration also recently announced more than $8.6 million for innovative programs to treat opioid addiction through grants awarded through New York State’s Opioid Settlement Fund.

People with question or requests for additional information should visit https://www.health.ny.gov/statistics/opioid/

Information on where to find nearby Syringe Exchange Program site locations can be found here.

New Yorkers struggling with an addiction, or whose loved ones are struggling, can find help and hope by calling the state’s toll-free, 24-hour, 7-day-a-week HOPEline at 1-877-8-HOPENY (1-877-846-7369) or by texting HOPENY (Short Code 467369). 

                                           -###-

Contact: New York State Department of Health   

518-474-2043 x. 2   

press@health.ny.gov   

facebook.com/NYSDOH

twitter.com/HealthNYGov

pinterest.com/nysdoh

health.ny.gov  

New York State Department of Health Launches New Harm Reduction Campaign to Help Reduce Overdoses

“Safer Choices” Campaign Designed to Promote Tools and Knowledge to Reduce Overdose Deaths in New York

ALBANY, N.Y. (February 9, 2023) – The New York State Department of Health today announced the launch of a new harm reduction campaign, “Safer Choices,” to help prevent overdose deaths across New York. The multi-media campaign, starting with a focus on social media platforms and web-based resources, is meant to equip individuals with an understanding of how to reduce overdose, as deadly fentanyl continues to be found in a wide variety of drugs. The campaign also continues to emphasize the importance of naloxone as a life-saving tool in the event of an overdose.   

“To help reduce the number of overdose deaths across the state, we need to make sure people who use drugs, and their family members and friends, know how to reduce the risk of overdose and how to respond should an overdose occur,” Acting State Health Commissioner Dr. James McDonald said. “This new campaign will not only save lives, but it will also serve to help reduce the bias and discrimination associated with a substance use disorder diagnosis.”

The campaign shares helpful information and steps for family members, friends, and persons who use drugs. Tips for family members and friends strongly recommending carrying naloxone in case they witness an overdose, as well as information about Opioid Overdose Training programs across the state and about the Naloxone Co-payment Assistance Program (N-CAP), which can  cover co-payments for naloxone of up to $40.

These important messages focus on other life-saving steps that can be taken, which include testing drugs for fentanyl contamination. Fentanyl, a synthetic opioid that is 50-100 times stronger than heroin, has been found in powder cocaine, crack cocaine, methamphetamine, molly/MDMA, counterfeit Xanax, other pills, and powder sold as heroin. In addition, the campaign advises individuals to never use opioids and other drugs alone, and to know that, in case of an overdose, calling 911 will not result in a possession charge. Persons who use drugs are also encouraged to carry naloxone and know how to administer this life-saving drug.

More information about the new harm reduction campaign can be found at https://www.health.ny.gov/saferchoices.

This latest campaign builds on the Department’s ongoing work to support a variety of harm reduction initiatives. Other programs include the Local Health Department Initiative, providing funding to 24 county health departments with the highest overdose rates outside of New York City to bolster primary care, corrections, harm reduction, emergency departments, public safety, and more; over 900 registered Opioid Overdose Prevention Programs, which provide training to non-medical individuals to recognize opioid overdoses and provide naloxone at no cost to the participant. The Department also operates New York MATTERS, an electronic referral system for connecting individuals with opioid use disorder to local treatment and harm reduction services.

Additionally, the State has authorized 25 Syringe Exchange Programs (SEPs) with over 81 sites statewide. SEPs remain at the forefront of innovation in addressing the needs of New Yorkers who use drugs and lead in the distribution of naloxone to New Yorkers vulnerable to overdose. The State’s 14 Drug User Health Hubs have been built upon the long-standing foundation of SEPs. These Hubs focus on reducing overdose by providing access to buprenorphine, building safety plans with people who have experienced a non-fatal overdose and equipping participants with naloxone.

Governor Hochul’s administration also recently announced more than $8.6 million for innovative programs to treat opioid addiction through grants awarded through New York State’s Opioid Settlement Fund.

People with question or requests for additional information should visit https://www.health.ny.gov/statistics/opioid/

Information on where to find nearby Syringe Exchange Program site locations can be found here.

New Yorkers struggling with an addiction, or whose loved ones are struggling, can find help and hope by calling the state’s toll-free, 24-hour, 7-day-a-week HOPEline at 1-877-8-HOPENY (1-877-846-7369) or by texting HOPENY (Short Code 467369). 

                                           -###-

Contact: New York State Department of Health   

518-474-2043 x. 2   

press@health.ny.gov   

facebook.com/NYSDOH

twitter.com/HealthNYGov

pinterest.com/nysdoh

health.ny.gov  

Dutchess Co. SEP Temporarily Operating Via Special Arrangements

Wednesday, February 8th, 2023

Our Dutchess County Syringe Exchange Program (SEP) is operating via special arrangements while our mobile health van undergoes some much-needed repairs. Prevention Specialists will be at our usual spot with their cars, and we are distributing harm reduction supplies as we always do. Things may look a little different for a few weeks, and you may not see our usual white van. If you’re in need and don’t see us on Mondays and Thursdays, call (914) 606-0316 or (845) 743-3133.

More About MATTERS: Webinar & Panel Discussion

Monday, August 22nd, 2022

September 7, 1-2pm – New York MATTERS is a statewide referral network that has connected over 1,000 individuals to essential medications for opioid use disorder and additional support services. They have developed an electronic referral platform (hosted by the New York State Department of Health) to efficiently refer patients with opioid use disorder from emergency departments along with OB/GYN offices, correctional facilities, inpatient units, pre-hospital settings, etc. to community-based clinics. The app is now available in the Apple and Google Play stores, helping to connect patients, providers, first responders, and community organizations.


Panelists include:
Caleigh Loughran, NYSDOH Program Manager
Matthew Fallico, MSW, NYSDOH Program Coordinator
Sarah Santos, Hudson Valley Regional Care Coordinator with HVCS
Emily Payne, MSPH, NYSDOH Epidemiologist & Data Evaluator

Join and learn more about this program. The panel will briefly describe its roots and reasons for its
success and growth beyond borders and beyond its technical platform. We will explore the data-driven
lessons learned from the growth of the program, the role of community partners and regional care
coordinators, and how it all dovetails with SEPs and Health Hubs. We are hosting this webinar as a meeting format to encourage dialogue and collaboration throughout. This webinar is free to attend.
After registering, you will receive a confirmation email containing information about joining the meeting.
REGISTER TODAY!

Health Hub Expands To Dutchess County

Monday, November 15th, 2021

Thanks to a grant from the Centers for Disease Control and Prevention (CDC), HVCS is now able to expand its Health Hub services to Dutchess County. The grant is administered by the New York State Department of Health AIDS Institute.

The Health Hub works with clients who have an opioid use disorder and provides them with prescriptions for buprenorphine, also known as Suboxone. This medication prevents the feelings of withdrawal without causing a “high.” People who are on Buprenorphine are able to avoid withdrawal, reduce their chances of relapse, and engage in healthier decisions. Clients access a medical professional on a regular basis: in this case, clients will meet with a provider from Cornerstone Family Healthcare via telehealth visits.

The regular contact required by the Buprenorphine prescription also allows staff to gain the client’s trust, address other livestyle issues such as food access, housing, HIV and STI testing, and refer them to any other necessary services.

The Health Hub has operated in Orange and Sullivan counties for many years. We are grateful to be the recipient of these funds so that we can expand a successful program with a proven track record of reducing the harm of opioids on another county in the Hudson Valley.

New Video: Fentanyl Test Strips

Friday, March 26th, 2021
https://youtu.be/y6qZL0qYiAc

How much do you know about fentanyl test strips? Why, and how, should you use them? When funding allows, we provide these for free to our clients. Be smarter and safer, test first!

NYS Withholding Payments to HVCS: Substance Use Programs Could Be Impacted

Friday, July 31st, 2020

Gotham Gazette reported on New York State’s withholding of payments on contractual services already provided by HVCS and its potential impact on programs and staffing. HVCS is not the only nonprofit facing this dilemma by far. Thanks to Gotham Gazette for covering this issue.

“With the pandemic blowing a hole in the economy and leading to a drastic drop in state tax revenue, budget officials have for months been withholding payments for state contracts to manage cash flows. Among the victims of that fiscal approach are substance use treatment providers who are being forced to cut already-limited services and consider staff layoffs and furloughs, which they say will likely lead to a sharp increase in overdoses and new disease outbreaks around the state.”

Read the full article here.